# A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19

> **NCT04522830** · PHASE2 · COMPLETED · sponsor: **Beech Tree Labs, Inc.** · enrollment: 28 (actual)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** BTL-TML-COVID
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04522830
- **Lead sponsor:** Beech Tree Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-30
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04522830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04522830, "A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04522830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*